B20
Human immunodeficiency virus [HIV] disease
Human Immunodeficiency Virus (HIV) disease (B20) represents the symptomatic stage of HIV infection or a diagnosis of Acquired Immunodeficiency Syndrome (AIDS). HIV is a retrovirus that selectively infects and depletes CD4+ T lymphocytes, the orchestrators of the human immune response. As CD4 counts decline, the patient becomes susceptible to a spectrum of opportunistic infections and malignancies. According to the 2026 ICD-10-CM guidelines, the code B20 is used for patients with any known history of HIV-related illness or those who have manifested clinical symptoms. This includes those with AIDS-defining conditions such as Kaposi's sarcoma, Pneumocystis jirovecii pneumonia, or wasting syndrome. Once a patient is diagnosed with B20-level disease, they are permanently classified as such for all future clinical encounters; the code does not revert to Z21 (asymptomatic status) even if symptoms resolve or viral load becomes undetectable under antiretroviral therapy (ART). Clinical management focuses on chronic viral suppression to prevent immune exhaustion and reduce transmission risk.
Clinical Symptoms
- Recurrent fever and chills
- Persistent night sweats
- Chronic, unexplained diarrhea
- Rapid and significant weight loss (HIV wasting syndrome)
- Oral candidiasis (Thrush)
- Generalized lymphadenopathy
- Persistent, extreme fatigue
- Shortness of breath or chronic dry cough (indicative of PJP)
- Kaposi's sarcoma (purple or brown skin lesions)
- Cytomegalovirus retinitis (vision loss)
- Cryptococcal meningitis (severe headache, neck stiffness)
- Esophageal candidiasis (painful swallowing)
- Persistent skin rashes or flaky skin
- Memory loss, confusion, or neurologic changes
- Recurrent bacterial pneumonia
Common Causes
- Infection with Human Immunodeficiency Virus Type 1 (HIV-1)
- Infection with Human Immunodeficiency Virus Type 2 (HIV-2)
- Unprotected sexual contact (vaginal, anal, or oral)
- Sharing of contaminated needles or syringes in injection drug use
- Vertical transmission from mother to child during pregnancy or childbirth
- Transmission through infected breast milk during breastfeeding
- Accidental needle-stick or sharps injuries in healthcare settings
- Transfusion of infected blood or blood products (historically significant, now rare)
- Organ or tissue transplantation from an infected donor
Documentation & Coding Tips
Explicitly differentiate between Asymptomatic HIV Status and HIV Disease.
Example: Patient with known history of HIV disease, previously diagnosed with PCP in 2022. Currently on Biktarvy with undetectable viral load and CD4 of 450. Assessment: HIV disease (B20), stable on HAART. Note: History of AIDS-defining illness requires B20 even if currently asymptomatic.
Billing Focus: Documentation must specify the presence of current or past opportunistic infections to justify B20 over Z21.
Prioritize sequencing based on the reason for the encounter.
Example: Chief Complaint: Evaluation of purple skin lesions. Physical Exam: Multiple violaceous plaques on lower extremities consistent with Kaposi Sarcoma. Assessment: 1. HIV Disease (B20). 2. Kaposi Sarcoma of skin (C46.0). Plan: Referral to oncology and dermatology for biopsy and systemic treatment evaluation.
Billing Focus: When an encounter is for an HIV-related condition, B20 is sequenced as the primary diagnosis followed by the manifestation codes.
Document specific opportunistic infections and associated complications.
Example: Patient with HIV disease presenting with severe headache and meningismus. Lumbar puncture positive for Cryptococcus neoformans. Assessment: 1. HIV Disease (B20). 2. Cryptococcal meningitis (B45.1). Patient is severely immunocompromised with CD4 count of 45. Initiating IV Amphotericin B.
Billing Focus: Linking the opportunistic infection to the HIV disease (B20) is essential for accurate DRG assignment in inpatient settings.
Clearly state the relationship between HIV and unrelated conditions.
Example: Patient with HIV disease presenting for evaluation of a traumatic right radius fracture. HIV is stable on current regimen and not impacting the management of the fracture. Assessment: 1. Displaced fracture of right radial shaft (S52.301A). 2. HIV Disease (B20). Fracture reduction and casting performed today.
Billing Focus: If the encounter is for an unrelated condition, code the unrelated condition first, followed by B20.
Verify and document the patient's current ART regimen and adherence.
Example: Patient with HIV disease here for routine follow-up. Currently prescribed Descovy and Tivicay. Patient reports 100 percent adherence over the last 30 days. Most recent viral load was undetectable 2 months ago. Assessment: HIV disease (B20), compliant with HAART.
Billing Focus: Supports the medical necessity of E/M level selection by demonstrating the management of a chronic condition with systemic medications.
Relevant CPT Codes
-
99214 - Office or other outpatient visit, established patient, moderate MDM
Typically used for routine follow-up of HIV patients where stable medications are managed but require monitoring for toxicity and viral suppression.
-
99215 - Office or other outpatient visit, established patient, high MDM
Appropriate for patients with HIV and multiple co-morbidities or those failing ART and requiring intensive regimen changes.
-
87536 - Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification
Standard of care for monitoring ART effectiveness and identifying virologic failure.
-
86360 - T cells; absolute CD4 and CD8 count, including ratio
Essential for staging the disease and determining the risk for specific opportunistic infections.
-
96365 - Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour
Used for administering IV medications for acute opportunistic infections like CMV or severe fungal infections.
-
99204 - Office or other outpatient visit, new patient, moderate MDM
Used for the initial evaluation of a patient newly diagnosed with HIV or a patient transferring care.
-
87539 - Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification
Used for patients suspected of having HIV-2 infection, which requires different ART considerations.
-
G0432 - Infectious agent antigen detection by enzyme immunoassay (EIA) technique, HIV-1 and/or HIV-2, screening
Used for preventative screening in asymptomatic individuals.
-
90677 - Pneumococcal conjugate vaccine, 20-valent (PCV20), for intramuscular use
HIV patients are at high risk for invasive pneumococcal disease and require specific immunization schedules.
-
99401 - Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual, approximately 15 minutes
Used for PrEP/PEP counseling or secondary prevention in HIV-positive individuals.
Related Diagnoses
- Z21 - Asymptomatic human immunodeficiency virus [HIV] infection status
- R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
- B59 - Pneumocystosis
- C46.0 - Kaposi's sarcoma of skin
- B45.1 - Cerebral cryptococcosis
- A31.2 - Disseminated mycobacterium avium-intracellulare complex (MAC)
- B37.1 - Pulmonary candidiasis
- Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]
- Z71.7 - Human immunodeficiency virus [HIV] counseling
- O98.712 - HIV disease complicating pregnancy, second trimester